The Nomination Committee of Elicera Therapeutics AB (publ) has thus unanimously proposed a re-election of the current Board. Karin Hoogendoorn has declined re-election.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.445 SEK | -2.36% |
|
+5.09% | -68.31% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-68.31% | 49.37L | |
+55.19% | 81TCr | |
+45.77% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+10.18% | 30TCr | |
+18.38% | 25TCr | |
+2.66% | 23TCr | |
+13.34% | 22TCr | |
+10.86% | 17TCr |
- Stock Market
- Equities
- ELIC Stock
- News Elicera Therapeutics AB
- Elicera Therapeutics AB Informs Karin Hoogendoorn Decline Re-Election to the Board